文献速递产科

活跃期停用缩宫素降低剖宫产风险:系统评价与Meta分析

Reduced risk of cesarean delivery with oxytocin discontinuation in active labor: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2025-03-18

该系统评价与Meta分析纳入15项随机对照试验共5734例患者,比较活跃期停用与继续使用缩宫素对剖宫产率的影响。停用缩宫素组剖宫产率较低(RR=0.80,95%CI 0.66-0.97),且子宫过度刺激和胎心监护异常风险降低,但活跃期延长约30分钟、第二产程延长约6分钟。结论认为该有益效应依赖于对可信度存疑研究的纳入。

要点

  • 活跃期停用缩宫素与剖宫产风险降低相关(RR=0.80,95%CI 0.66-0.97)。
  • 停用缩宫素降低子宫过度刺激(RR=0.45)和胎心监护异常(RR=0.64)风险。
  • 停用缩宫素使活跃期平均延长30分钟、第二产程平均延长6分钟。

核心结论

  • 活跃期停用缩宫素虽使产程延长约半小时,但与剖宫产风险降低20%相关,且子宫过度刺激和胎心监护异常风险较低。
  • 汇总分析提示有益效应,但该发现依赖于对可信度存疑研究的纳入。

研究设计与样本

  • 系统评价与Meta分析,检索数据库自建库至2024年2月,方案注册于PROSPERO。
  • 纳入15项随机对照试验,共5734例患者;纳入接受缩宫素引产或加强宫缩的孕妇,比较活跃期停用与继续使用缩宫素。
  • 排除非随机试验、准随机试验和动物模型;活跃期定义依据各试验。

主要发现

  • 剖宫产率在13项研究中报告,停用缩宫素组较低(RR=0.80;95%CI 0.66-0.97;95%预测区间0.38-1.22)。
  • 停用缩宫素与子宫过度刺激风险降低相关(RR=0.45;95%CI 0.34-0.60;I²=26%)。
  • 停用缩宫素与胎心监护异常风险降低相关(RR=0.64;95%CI 0.49-0.82;I²=41%)。
  • 停用缩宫素使活跃期平均延长30分钟,第二产程平均延长6分钟。

局限性

  • 汇总分析的有益效应依赖于对可信度存疑研究的纳入。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Our objective was to determine if oxytocin discontinuation in the active phase of labor impacts the rate of cesarean delivery compared to continuation of oxytocin. DATA SOURCES: This study was a systematic review and meta-analysis of randomized controlled trials. A research librarian performed a database search using a combination of standardized terms and keywords related to oxytocin discontinuation and stages of labor from database inception until February 2024. This protocol was registered in The International Prospective Register of Systematic Reviews (PROSPERO). STUDY ELIGIBILITY CRITERIA: Randomized controlled trials of pregnant patients who received oxytocin for induction or augmentation of labor, whose outcomes compared discontinuation and continuation of oxytocin in active labor, were included. We defined "active phase of labor" as defined by each trial. Nonrandomized trials, quasi-randomized trials, and animal models were excluded. The primary outcome was the rate of cesarean delivery. Secondary maternal outcomes included postpartum hemorrhage, total blood loss, and infectious outcomes. Secondary neonatal outcomes included Apgar score at 5 minutes <7, umbilical arterial pH <7.10, neonatal therapeutic hypothermia, neonatal intensive care unit admission, neonatal resuscitation at birth, and neonatal death. STUDY APPRAISAL AND SYNTHESIS METHODS: The risk of bias in each study was assessed using the guidelines outlined in the Cochrane Handbook for Systematic Reviews of Interventions. Heterogeneity was measured using Higgins I2. Meta-analysis was performed in Review Manager 5.4.1 and StataSE 16 to determine summary treatment effects in terms of relative risk or mean difference with 95% confidence intervals. The adherence of each included trial to the trustworthiness criteria outlined by the OBGYN Editors' Integrity Group was assessed, and a leave-1-out analysis was performed to evaluate the effect of studies with concerns regarding trustworthiness. RESULTS: Fifteen randomized controlled trials, including 5734 patients, were ultimately included in the meta-analysis. The rate of cesarean delivery, reported in 13 studies, was lower with discontinuation of oxytocin in the active phase of labor (relative risk=0.80; 95% confidence interval, 0.66-0.97; 95% prediction interval, 0.38-1.22). Discontinuation of oxytocin was also associated with a lower risk of uterine tachysystole (relative risk=0.45; 95% confidence interval, 0.34-0.60; I2, 26%), and nonreassuring fetal heart rate tracing (relative risk=0.64; 95% confidence interval, 0.49-0.82; I2, 41%). Discontinuation of oxytocin increased the duration of active labor by an average of 30 minutes and second stage of labor by an average of 6 minutes. CONCLUSION: Although associated with an extension of labor by half an hour, discontinuation of oxytocin in the active phase of labor was associated with a 20% decreased risk of cesarean delivery and a lower risk of uterine tachysystole and nonreassuring fetal heart rate tracing. While the pooled analysis suggests a beneficial effect, this finding is dependent on the inclusion of studies with concerns regarding trustworthiness.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Whitley J, Burd J, Doering M, et al. Reduced risk of cesarean delivery with oxytocin discontinuation in active labor: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025. PMID: 40113155. doi:10.1016/j.ajog.2025.03.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。